Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Neuroprotection
100%
Estrogen
100%
Insulin-like Growth factor-1
33%
Global Ischemia
26%
ER-β
26%
Cardiac Arrest
20%
Apoptotic Cell Death
20%
Signaling Cascades
13%
Cardiac Surgery
13%
Ischemia
13%
Insulin-like Growth Factor 1 Receptor (IGF1R)
13%
Hippocampal Neurons
13%
Hippocampal Damage
13%
Molecular Genetic Testing
6%
Occlusion Model
6%
Hypoestrogenemia
6%
Mitogen-activated Protein Kinase
6%
Estrogen Replacement Therapy
6%
ER Antagonist
6%
Molecular Mechanism
6%
Term-equivalent Age
6%
Protein Kinase B
6%
Neuroprotective Action
6%
Genomic Action
6%
Postmenopausal Women
6%
Cerebral Stroke
6%
Cellular Targets
6%
Menopause
6%
Apoptotic Pathway
6%
Delayed Neuronal Death
6%
Pharmacological Studies
6%
Beta-knockout Mice
6%
Targeted Deletion
6%
2-vessel Occlusion
6%
Hippocampal CA1 Region
6%
Long-term Treatment
6%
Mitogen-activated Protein Kinase Inhibitor
6%
Caspase
6%
Receptor Antagonist
6%
Subtype-specific
6%
Forkhead
6%
Hippocampus
6%
Estrogen Receptor
6%
Specific Aims
6%
Physiological Level
6%
Neuroscience
Estrogen
100%
Neuroprotection
100%
Ischemia
40%
Programmed Cell Death
20%
Protein Kinase B
13%
Genetics
13%
Mitogen-Activated Protein Kinase
13%
Hippocampus
6%
Caspase
6%
Kinase
6%
Protein Kinase Inhibitor
6%
Insulin-Like Growth Factor 1 Receptor
6%
Neuronal Cell Death
6%
Cerebrovascular Accident
6%
Receptor Antagonist
6%
Agonist
6%
Estrogen Replacement Therapy
6%
Estrogen Receptor
6%
Neuroprotective Agent
6%